UCB VENTURES

ucb-ventures-logo

UCB Ventures is a โ‚ฌ150 million strategic corporate venture fund

#SimilarOrganizations #People #Financial #More

UCB VENTURES

Social Links:

Founded:
2017-01-01

Status:
Active

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Tag Manager Google Analytics Content Delivery Network SSL By Default Global Site Tag HSTS Google Universal Analytics


Similar Organizations

ibi-tech-fund-logo

IBI Tech Fund

IBI Tech Fund is an Israeli fund investing in early-stage outstanding startups.

Current Employees Featured

erica-whittaker_image

Erica Whittaker
Erica Whittaker Head of UCB Ventures @ UCB Ventures
Head of UCB Ventures

delphine-hajaji_image

Delphine Hajaji
Delphine Hajaji Partner @ UCB Ventures
Partner

alicia-iruzun-lafitte_image

Alicia Iruzun Lafitte
Alicia Iruzun Lafitte Partner @ UCB Ventures
Partner

emmanuel-lacroix_image

Emmanuel Lacroix
Emmanuel Lacroix Partner @ UCB Ventures
Partner

joshua-sands_image

Joshua Sands
Joshua Sands Principal @ UCB Ventures
Principal

steven-biesmans_image

Steven Biesmans
Steven Biesmans Executive @ UCB Ventures
Executive

Investments List

Date Company Article Money raised
2024-02-08 Neurona Therapeutics UCB Ventures investment in Series E - Neurona Therapeutics 120 M USD
2023-11-13 ViaNautis UCB Ventures investment in Series A - ViaNautis 20 M GBP
2023-03-14 Switch Therapeutics UCB Ventures investment in Series A - Switch Therapeutics 52 M USD
2022-06-07 Code Biotherapeutics UCB Ventures investment in Series A - Code Biotherapeutics 75 M USD
2022-02-15 Splice Bio UCB Ventures investment in Series A - Splice Bio 50 M EUR
2021-09-30 EsoBiotec UCB Ventures investment in Seed Round - EsoBiotec 3 M EUR
2021-06-22 Neurona Therapeutics UCB Ventures investment in Venture Round - Neurona Therapeutics 41.5 M USD
2021-04-20 Rinri Therapeutics UCB Ventures investment in Venture Round - Rinri Therapeutics 10 M EUR
2021-03-16 StrideBio UCB Ventures investment in Series B - StrideBio 81.5 M USD
2020-12-14 Locanabio UCB Ventures investment in Series B - Locanabio 100 M USD

More informations about "UCB Ventures"

Team - UCB Ventures

Reiner Class joined UCB Ventures in September 2024. Reiner started his journey at UCB in 2016 as Associate Director in Investigative Toxicology and transitioned to DMPK in 2023. Prior to joining UCB, Reiner spent 10 years at the largest โ€ฆSee details»

UCB

UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions ... UCB Ventures invests in pioneering companies and technologies โ€ฆSee details»

UCB Ventures Org Chart + Executive Team - The Official Board

Organizational Chart of UCB Ventures. UCB Ventures Org Chart www.ucbventures.com. has 3 executives - and belongs to UCB +32 2559 9999; Add an executive. UCB Ventures (UCB) โ€ฆSee details»

Portfolio - UCB Ventures

Our Portfolio Direct Investments. We take an active role in our portfolio companies, contributing expertise in drug discovery, development and operations, to help them deliver maximum patient value.See details»

UCB Ventures - LinkedIn

UCB Ventures | 890 followers on LinkedIn. We are life science investors focusing on next-generation therapies. | UCB Ventures is the strategic corporate venture fund of UCB Pharma. Our mission is to further strengthen UCB's ability โ€ฆSee details»

UCB Ventures - Crunchbase Investor Profile

Find More Contacts for UCB Ventures. Protected Content. Associate. Non-Management Management 1 email found . View contacts for UCB Ventures to access new leads and connect with decision-makers. View All Contacts . โ€ฆSee details»

UCB Ventures - Power, Precision & Agility (Massachusetts / United ...

UCB Ventures is an evergreen strategic corporate venture fund established in 2017 to further strengthen UCB's ability to create value from novel insights and technologies that can โ€ฆSee details»

UCB Ventures | UCB

Aug 10, 2020 ExeVir Bio: Collaborating and contributing to the fight against the global pandemic Read MoreSee details»

UCB Ventures - Investments, Portfolio & Company Exits

UCB Ventures 's most notable exits include EsoBiotec, MyHealthTeams, and Syndesi Therapeutics. Which industries has this organization had the most exits in? Show . EsoBiotec โ€ฆSee details»

UCB Ventures investment portfolio - PitchBook

UCB Ventures General Information Company Description. Founded in 2017, UBC Ventures is a venture arm of UCB based in Cambridge, Massachusetts. The firm seeks to invest in start-ups โ€ฆSee details»

UCB Ventures | UCB

UCB Ventures and AXA Venture Partners: seeking innovation in digital health Read MoreSee details»

Our News - UCB Ventures

Mar 13, 2025 UCB Ventures and AXA Venture Partners: seeking innovation in digital health. 18 Feb 2021. In this interview, UCB Ventures Partner, Delphine Hajaji, connects with François โ€ฆSee details»

UCB Ventures - Contacts, Employees, Board Members

UCB Ventures has 6 current employee profiles, including Head of UCB Ventures Erica Whittaker. Contacts. Edit Contacts Section. Job Department. Protected Content. Venture Capital โ€ฆSee details»

UCB Ventures Company Profile | Bruxelles, Belgium | Competitors ...

Find company research, competitor information, contact details & financial data for UCB Ventures of Bruxelles. Get the latest business insights from Dun & Bradstreet.See details»

UCB Ventures and AXA Venture Partners: seeking innovation in โ€ฆ

Feb 18, 2021 Delphine (D): Healthcare innovation has the potential to improve the lives of patients dramatically. And that is exactly why UCB Ventures has specifically been investing in โ€ฆSee details»

UCB Ventures - EU-Startups

UCB Ventures is a โ‚ฌ150 million strategic corporate venture fund. UCB is a global biopharmaceutical company focused on neurology and immunology disorders, driven by โ€ฆSee details»

UCB Venture Fund: Performance - PitchBook

UCB Venture Fund is an early stage venture capital fund mangled by UCB Ventures. The fund is located in Cambridge, Cambridge. The fund targets pharmaceuticals and biotechnology, โ€ฆSee details»

UCB Ventures makes its first direct investment

Erica Whittaker, PhD, Vice President, Head of UCB Ventures, and Jayson Punwani, PhD, Partner, Takeda Ventures, Inc. have joined StrideBioโ€™s Board of Directors. UCB Ventures is a strategic โ€ฆSee details»

On Growth Path for a Decade plus: Strong Launch Execution โ€ฆ

Feb 27, 2025 UCB Full-Year Report 2024, Brussels (Belgium), 27 February 2025 โ€“ 7:00 (CET) โ€“ regulated information . Jean-Christophe Tellier, CEO UCB says: โ€œOur 2024 performance โ€ฆSee details»

To Make Better Decisions, Think Like a Venture Capitalist

2 days ago April 02, 2025. Venture capital firms notoriously embrace risk and take big swings, hoping that one startup will become a monster hit that pays for many other failed investments.See details»

linkstock.net © 2022. All rights reserved